E Torlakovic

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi B-cell markers in lymphocyte predominance Hodgkin disease
    Emina Torlakovic
    Department of Pathology, The Norweigian Radium Hospital, Oslo, Norway
    Arch Pathol Lab Med 126:862-3. 2002
  2. ncbi The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker
    Emina Torlakovic
    Department of Pathology, Noewegian, Radium Hospital, Oslo, Norway
    Am J Surg Pathol 26:1343-50. 2002
  3. pmc The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease
    E Torlakovic
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Am J Pathol 159:1807-14. 2001
  4. ncbi Follicular colonization by follicular lymphoma
    Emina Torlakovic
    Department of Pathology, The Norwegian Radium Hospital, Oslo
    Arch Pathol Lab Med 126:1136-7. 2002
  5. ncbi Detection of immunoglobulin heavy chain gene rearrangements by polymerase chain reaction analysis on lymph node imprints and fine-needle aspirate smears: a comparison of five different imprint preparations
    E Torlakovic
    Department of Pathology, Norwegian Radium Hospital, Oslo, Norway
    Diagn Cytopathol 20:333-8. 1999
  6. ncbi Cultured anaplastic cell lines as immunocytochemistry controls: a comparison of ThinPrep-processed smears and conventional air-dried cytospins
    B A Wiatrowska
    Department of Pathology, Norwegian Radium Hospital, Oslo, Norway
    Diagn Cytopathol 25:303-8. 2001
  7. ncbi CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD
    A K Blystad
    Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway
    Cytotherapy 3:295-305. 2001
  8. ncbi Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
    W Lilleby
    Department of Clinical Radiotherapy, The Norwegian Radium Hospital, The University of Oslo, Oslo, Norway
    Cancer 92:311-9. 2001
  9. ncbi Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study
    M Jerkeman
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Int J Oncol 20:161-5. 2002
  10. ncbi Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile
    A V Bassarova
    Department of Pathology, Alexander University Hospital, Medical University, Sofia, Bulgaria
    Histol Histopathol 20:791-9. 2005

Collaborators

Detail Information

Publications10

  1. ncbi B-cell markers in lymphocyte predominance Hodgkin disease
    Emina Torlakovic
    Department of Pathology, The Norweigian Radium Hospital, Oslo, Norway
    Arch Pathol Lab Med 126:862-3. 2002
  2. ncbi The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker
    Emina Torlakovic
    Department of Pathology, Noewegian, Radium Hospital, Oslo, Norway
    Am J Surg Pathol 26:1343-50. 2002
    ....
  3. pmc The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease
    E Torlakovic
    Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
    Am J Pathol 159:1807-14. 2001
    ..The lack of PU.1 protein expression in cHD likely contributes to the lack of immunoglobulin expression and incomplete B-cell phenotype characteristic of the Reed-Sternberg cells in cHD...
  4. ncbi Follicular colonization by follicular lymphoma
    Emina Torlakovic
    Department of Pathology, The Norwegian Radium Hospital, Oslo
    Arch Pathol Lab Med 126:1136-7. 2002
  5. ncbi Detection of immunoglobulin heavy chain gene rearrangements by polymerase chain reaction analysis on lymph node imprints and fine-needle aspirate smears: a comparison of five different imprint preparations
    E Torlakovic
    Department of Pathology, Norwegian Radium Hospital, Oslo, Norway
    Diagn Cytopathol 20:333-8. 1999
    ..In a prospective study with 19 fine-needle aspirate specimens, the efficiency of the PCR increased to 100%, and sensitivity improved to 81%...
  6. ncbi Cultured anaplastic cell lines as immunocytochemistry controls: a comparison of ThinPrep-processed smears and conventional air-dried cytospins
    B A Wiatrowska
    Department of Pathology, Norwegian Radium Hospital, Oslo, Norway
    Diagn Cytopathol 25:303-8. 2001
    ..ThinPrep-processed slides from clinical samples are ideal for immunocytochemistry, because internal negative controls can be performed for each test. We recommend the use of cytospins for positive controls because of the lower cost...
  7. ncbi CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HD
    A K Blystad
    Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway
    Cytotherapy 3:295-305. 2001
    ..DISCUSSION: We show that contaminating atypical CD30(+) cells in PBPC can efficiently be removed by CD34(+) cell enrichment, and the use of such grafts following HDT gives fast and sustained engraftment...
  8. ncbi Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
    W Lilleby
    Department of Clinical Radiotherapy, The Norwegian Radium Hospital, The University of Oslo, Oslo, Norway
    Cancer 92:311-9. 2001
    ..The current study was conducted to evaluate and compare the impact of two major histologic grading systems on failure-free survival in patients with prostate carcinoma who are treated with definitive radiation...
  9. ncbi Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study
    M Jerkeman
    Department of Oncology, Lund University Hospital, SE 221 85 Lund, Sweden
    Int J Oncol 20:161-5. 2002
    ..Assessment of BCL6 status may, however, be of clinical interest when related to other prognostic variables...
  10. ncbi Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile
    A V Bassarova
    Department of Pathology, Alexander University Hospital, Medical University, Sofia, Bulgaria
    Histol Histopathol 20:791-9. 2005
    ..The aim of this study was to compare clinicopathological characteristics and immunohistochemical profiles of simultaneous BBC and corresponding lymph node metastases in eight patients...